Across TCGA pan-cancer cohorts, OR9H1P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OR9H1P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where OR9H1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR9H1P is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD, PRAD, and THCA are the cancer types where OR9H1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR9H1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.042	.002	4	view →
PRAD	All	All	+0.056	.016	2	view →
THCA	Female	All	−0.027	.011	2	view →
STAD	Male	II,III,IV	−0.037	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: OR9H1P RNA expression & survival · all OR9H1P data types